Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway

被引:56
|
作者
Ding, Jieqiong [1 ,2 ]
Tang, Qiong [1 ,2 ]
Luo, Binhua [3 ]
Zhang, Lijun [1 ]
Lin, Li [1 ]
Han, Lu [1 ]
Hao, Miaomiao [3 ]
Li, Mingyue [3 ]
Yu, Liangzhu [1 ,2 ]
Li, Mincai [1 ,2 ]
机构
[1] Hubei Univ Sci & Technol, Sch Basic Med Sci, Xianning 437100, Peoples R China
[2] Hubei Univ Sci & Technol, Hubei Key Lab Cardiovasc Cerebrovasc & Metab Diso, Xianning 437100, Peoples R China
[3] Hubei Univ Sci & Technol, Sch Pharm, Xianning 437100, Peoples R China
基金
中国国家自然科学基金;
关键词
Klotho; Hypertrophy; Fibrosis; Transforming growth factor-beta 1; Angiotensin II; LEFT-VENTRICULAR HYPERTROPHY; GROWTH-FACTOR-BETA; PROGRESSION; EXPRESSION; RECEPTORS; MODEL;
D O I
10.1016/j.ejphar.2019.172549
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent studies have revealed critical roles of transforming growth factor-beta 1 (TGF-beta 1) and microRNA-132 (miR-132), a downstream mediator of TGF-beta 1, in the pathogenesis of cardiac remodeling. In this study, we tested whether the antiaging protein klotho modifies angiotensin II (Ang II)-induced cardiac remodeling through regulating TGF-beta 1-miR-132 axis. We found that both klotho and the TGF-beta 1 inhibitor LY364947 significantly inhibited cardiac hypertrophy, fibrosis, and dysfunction in Ang II-infused mice, as evidenced by the ratios of heart weight to body weight (HW/BW), heart weight to tibial length (HW/TL), cardiomyocyte cross-sectional area, fibrotic area, and expression of prohypertrophic genes (ANP, beta-MHC) and fibrotic marker genes (alpha-SMA, collagen I), echocardiographic parameters. Meanwhile, klotho also significantly inhibited Ang II-induced protein expression of TGF-beta 1 and phosphorylated Smad2/3 in the heart tissues and cultured cardiomyocytes and cardiac fibroblasts. In vitro experiments demonstrated that Ang II-induced cardiomyocyte hypertrophy and proliferation and activation of cardiac fibroblasts were markedly inhibited by klotho, LY364947 or the miR-132 inhibitor antimiR-beta 2. Both klotho and the TGF-beta 1 inhibitor LY364947 downregulated the miR-132 expression. Additionally, klotho decreased Ang II-induced protein expressions of cardiac fibroblast growth factor (FGF)23 in vivo and in vitro. The decreased protein levels of klotho in serum and renal tissues of Ang II-infused mice were elevated by klotho. Klotho downregulated the protein levels of TGF-beta 1 in renal tissues of Ang II-infused mice. In conclusion, our results suggest that klotho prevents Ang II-induced cardiac remodeling and dysfunction through modifying the TGF-beta 1-miR-132 axis, providing an experimental basis for clinical treatment on cardiac remodeling.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Mechanism of Dandelion Sterol in Treating Pulmonary Fibrosis Through Transforming Growth Factor-β Signaling Pathway
    Lv, Qun
    Wang, Jianjun
    Ruan, Zhaoyang
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (04) : 612 - 618
  • [42] Corilagin inhibits angiotensin II-induced atrial fibrosis and fibrillation in mice through the PI3K-Akt pathway
    Zhang, Xiaogang
    Tian, Bei
    Cong, Xinpeng
    Ning, Zhongping
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2024, 27 (06) : 717 - 724
  • [43] Combining experiments and bioinformatics to identify transforming growth factor-β1 as a key regulator in angiotensin II-induced trophoblast senescence
    Zhang, Wenni
    Cai, Shuangming
    Wu, Fei
    Luo, Yiping
    Xiao, Huanshun
    Yu, Danfeng
    Zhong, Xuan
    Tao, Pei
    Huang, Shan
    PLACENTA, 2024, 152 : 31 - 38
  • [44] Role of integrin alpha1beta1 in cardiac fibrosis and remodelling in angiotensin II-induced cardiac hypertrophy
    Louis, H.
    Kakou, A.
    Lacolley, P.
    Gardner, H.
    Wagner, D.
    Rouy, D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 554 - 555
  • [45] Muscone inhibits angiotensin II-induced cardiac hypertrophy through the STAT3, MAPK and TGF-β/SMAD signaling pathways
    Liu, Yi-jiang
    Xu, Jia-jia
    Yang, Cui
    Li, Yan-lin
    Chen, Min-wei
    Liu, Shi-xiao
    Zheng, Xiang-hui
    Luo, Ping
    Li, Rui
    Xiao, Di
    Shan, Zhong-gui
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [46] Metformin Inhibits Transforming Growth Factor-β1 And Cardiac Fibrosis by Targeting Hepatocyte Nuclear Factor 4α
    Xiao, Han
    Chen, Ruifei
    Feng, Yenan
    Wu, Jimin
    Song, Yao
    Zhang, Youyi
    CIRCULATION, 2016, 134
  • [47] (-)-Epicatechin Suppresses Angiotensin II-induced Cardiac Hypertrophy via the Activation of the SP1/SIRT1 Signaling Pathway
    Dong, Zeng-xiang
    Wan, Lin
    Wang, Ren-jun
    Shi, Yuan-qi
    Liu, Guang-zhong
    Zheng, Si-jia
    Hou, Hui-ling
    Han, Wei
    Hai, Xin
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (05) : 2004 - 2015
  • [48] Klotho overexpression protects against renal aging along with suppression of transforming growth factor-β1 signaling pathways
    Oishi, Hiroaki
    Doi, Shigehiro
    Nakashima, Ayumu
    Ike, Takeshi
    Maeoka, Yujiro
    Sasaki, Kensuke
    Doi, Toshiki
    Masaki, Takao
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 321 (06) : F799 - F811
  • [49] FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway
    Jin, Daoxin
    Han, Fangfang
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2020, 40 (06) : 493 - 500
  • [50] Hepatocyte Growth Factor Attenuates Transforming Growth Factor-β-Angiotensin II Crosstalk Through Inhibition of the PTEN/Akt Pathway
    Iekushi, Kazuma
    Taniyama, Yoshiaki
    Kusunoki, Hiroshi
    Azuma, Junya
    Sanada, Fumihiro
    Okayama, Keita
    Koibuchi, Nobutaka
    Iwabayashi, Masaaki
    Rakugi, Hiromi
    Morishita, Ryuichi
    HYPERTENSION, 2011, 58 (02) : 190 - U136